In this pilot study, itraconazole was administered to 18 patients with tinea corporis. The dosage was 100 mg daily for four to six weeks. Follow-up visits took place two, four, and six weeks after the ...

Please provide your email address to receive an email when new articles are posted on . A 3-year-old girl presents with concern for a rash on her right hip. Her mother first noticed it 7 months ago, ...

Reviews of Infectious Diseases, Vol. 9, Supplement 1. First International Symposium on Itraconazole (Jan. - Feb., 1987), pp. S104-S108 (5 pages) Itraconazole, the first orally active triazole ...

Please provide your email address to receive an email when new articles are posted on . An 8-year-old girl presents to your office with a rash unresponsive to therapy. She first noticed pink papules ...

The atypical lesions referred to as tinea incognito are the result of morphologic changes induced by topical corticosteroid treatment of tinea corporis. The changes may include loss of the raised, ...

A 30-year-old mixed martial arts fighter whose training partners had recently received diagnoses of tinea corporis presented with a 4-week history of pruritic cutaneous lesions. He had no relevant ...

Request To Download Free Sample of This Strategic Report @ :- https://reportocean.com/industry-verticals/sample-request?report_id=bw7051 Tinea Corporis Drugs Market ...

The US Food and Drug Administration (FDA) has approved the azole antifungal luliconazole 1% cream (Luzu, Valeant Pharmaceuticals) to treat fungal infections, the company announced today. Luliconazole ...